PMID- 38164682 OWN - NLM STAT- MEDLINE DCOM- 20240103 LR - 20240213 IS - 1552-3365 (Electronic) IS - 0363-5465 (Linking) VI - 52 IP - 1 DP - 2024 Jan TI - Hip Arthroscopic Surgery With Chondrolabral Refixation, Osteochondroplasty, and Routine Capsular Closure for Femoroacetabular Impingement Syndrome: Clinical Outcomes at a Minimum 10-Year Follow-up. PG - 24-33 LID - 10.1177/03635465231212663 [doi] AB - BACKGROUND: Hip arthroscopic surgery for femoroacetabular impingement syndrome (FAIS) has proven to be an effective surgical intervention, with high rates of return to sport and work as well as favorable outcomes at short- and midterm follow-up. However, limited data exist on outcomes at long-term follow-up. PURPOSE: To evaluate patient-reported outcomes (PROs) at a minimum 10-year follow-up after primary hip arthroscopic surgery including labral repair, femoral osteochondroplasty, acetabular osteochondroplasty, and capsular closure for FAIS. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Patients who underwent primary hip arthroscopic surgery for FAIS between June 2012 and January 2013 were identified. PROs were collected preoperatively and at a minimum of 10 years postoperatively, including the Hip Outcome Score-Activities of Daily Living (HOS-ADL), Hip Outcome Score-Sports Subscale (HOS-SS), modified Harris Hip Score (mHHS), International Hip Outcome Tool-12 (iHOT-12), and visual analog scale (VAS) for pain and satisfaction. Unique minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds were calculated, and their rates of achievement were analyzed. An alpha level of <.05 was used to determine statistical significance. RESULTS: A total of 94 patients (55 female; mean age, 34.3 +/- 12.4 years) were analyzed with a mean follow-up of 10.1 +/- 0.3 years (range, 10.0-10.7 years). Patients demonstrated significant 10-year improvement across all PRO measures (P < .001). MCID and PASS thresholds were calculated as follows: HOS-ADL (10.4 and 85.3, respectively), HOS-SS (14.6 and 60.2, respectively), mHHS (8.8 and 76.0, respectively), VAS pain (14.6 and 27.5, respectively), and iHOT-12 (PASS: 71.4). The majority of patients achieved the MCID and PASS for each PRO measure: HOS-ADL (73.4% and 70.9%, respectively), HOS-SS (78.5% and 77.2%, respectively), mHHS (81.0% and 70.9%, respectively), VAS pain (88.6% and 70.9%, respectively), and iHOT-12 (PASS: 73.4%). Overall, 9 patients (9.6%) underwent subsequent revision hip arthroscopic surgery at a mean 4.9 +/- 3.7 years (range, 1.1-10.1 years) postoperatively, and 6 patients (6.4%) underwent conversion to total hip arthroplasty at a mean 4.1 +/- 3.1 years (range, 0.9-9.3 years) postoperatively. CONCLUSION: Patients who underwent primary hip arthroscopic surgery for FAIS utilizing contemporary methods of labral repair, acetabular and/or femoral osteochondroplasty, and capsular closure commonly experienced sustained clinical improvement and reported high levels of satisfaction at a minimum 10-year follow-up with low rates of reoperation. FAU - Allahabadi, Sachin AU - Allahabadi S AUID- ORCID: 0000-0002-1185-3039 AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. AD - Division of Sports Medicine, Department of Orthopedic Surgery, Houston Methodist, Houston, Texas, USA. FAU - Chapman, Reagan S AU - Chapman RS AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. FAU - Fenn, Thomas W AU - Fenn TW AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. FAU - Brusalis, Christopher M AU - Brusalis CM AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. AD - Division of Sports Medicine, Department of Orthopedic Surgery, Hospital for Special Surgery, New York, New York, USA. FAU - Kaplan, Daniel J AU - Kaplan DJ AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. AD - Division of Sports Medicine, Department of Orthopedic Surgery, New York University Langone, New York, New York, USA. FAU - Nho, Shane J AU - Nho SJ AD - Section of Young Adult Hip Surgery, Division of Sports Medicine, Department of Orthopaedic Surgery, Rush University Medical Center, Rush Medical College of Rush University, Chicago, Illinois, USA. LA - eng PT - Journal Article PL - United States TA - Am J Sports Med JT - The American journal of sports medicine JID - 7609541 SB - IM MH - Humans MH - Female MH - Young Adult MH - Adult MH - Middle Aged MH - *Femoracetabular Impingement/surgery MH - Hip Joint/surgery MH - Follow-Up Studies MH - Treatment Outcome MH - Arthroscopy/methods MH - Activities of Daily Living MH - Pain MH - Patient Reported Outcome Measures MH - Retrospective Studies OTO - NOTNLM OT - femoroacetabular impingement OT - hip OT - hip arthroscopic surgery OT - long term COIS- One or more of the authors has declared the following potential conflict of interest or source of funding: S.A. has received support for education from Smith+Nephew. C.M.B. has received support for education from Smith+Nephew and hospitality payments from Exactech. S.J.N. has received research support from AlloSource, Arthrex, Athletico, DJ Orthopedics, Linvatec, MioMed, and Smith+Nephew; consulting fees from Ossur, SI-BONE, Springer, and Stryker; royalties from Ossur, Springer, and Stryker; and support for education from Elite Orthopaedics. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. EDAT- 2024/01/02 11:45 MHDA- 2024/01/03 09:44 CRDT- 2024/01/02 04:13 PHST- 2024/01/03 09:44 [medline] PHST- 2024/01/02 11:45 [pubmed] PHST- 2024/01/02 04:13 [entrez] AID - 10.1177/03635465231212663 [doi] PST - ppublish SO - Am J Sports Med. 2024 Jan;52(1):24-33. doi: 10.1177/03635465231212663.